Filing Details
- Accession Number:
- 0001209191-23-052348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-06 16:56:46
- Reporting Period:
- 2023-10-04
- Accepted Time:
- 2023-10-06 16:56:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861560 | Nuvalent Inc. | NUVL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1862148 | Darlene Noci | C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-10-04 | 4,587 | $1.08 | 4,587 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-10-04 | 15,413 | $6.89 | 20,000 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-10-04 | 14,600 | $55.41 | 5,400 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-10-04 | 5,400 | $57.54 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2023-10-04 | 4,587 | $0.00 | 4,587 | $1.08 |
| Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2023-10-04 | 15,413 | $0.00 | 15,413 | $6.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 71,802 | 2031-02-15 | No | 4 | M | Direct | |
| 26,351 | 2031-04-29 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2022.
- The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Billionaire Hedge Funds
